If you've read our piece on allostatic overload, you already know the core idea: your body keeps a running tally of every stressor it absorbs, and when the tally runs too high for too long, the cost shows up in your biology, not just your mood. What we haven't covered yet is a question a lot of you have been asking us directly: can the device on your wrist see any of this happening?
The honest answer is: partly, and it's worth understanding exactly which part.
What your wearable is measuring
Most consumer wearables that claim to track "stress" are really measuring heart rate variability, or HRV, the tiny, natural variation in the time between each heartbeat. It sounds like a strange thing to obsess over, but HRV is one of the more direct windows we have into your autonomic nervous system, the part of you constantly negotiating between rest-and-digest and fight-or-flight without asking your permission first.
Research groups have been validating this for a while now. A pilot study using smartwatch-based HRV tracking found that changes in heart rate variability could help predict how someone's body responded to an induced stressor, distinguishing recovery quality between people with different baseline stress profiles. Separately, a research review from the Texas Heart Institute noted that consumer-grade HRV monitoring compares reasonably well against medical-grade equipment, and that low HRV correlates with elevated cardiovascular risk.
None of that means your watch is diagnosing you. It means it's picking up something physiological that is related to how your body is handling load, though how closely varies from device to device, which is precisely the territory allostatic load research lives in. On burnout specifically, though, the answer to this article's title is no: a 2026 systematic review of burnout biomarkers found HRV results pointing in different directions across studies, and concluded that no biomarker can currently be used to diagnose burnout.
The newer frontier: glucose, not just heart rate
The more interesting shift over the last couple of years has been continuous glucose monitors, or CGMs, moving well beyond their original diabetes-management purpose. Researchers are now looking at what glucose variability can tell us in people without diabetes, including how it relates to sleep, activity and stress markers. One 14-day observational study of 105 adults in India, 53 without diabetes and 52 with pre-diabetes, used a continuous glucose monitor and a Fitbit, and reported that some glucose variability measures were strongly linked with inflammation in the pre-diabetic group, while sleep and activity were modestly linked in the non-diabetic group. The study also tested cortisol, but its abstract does not report a clear result for it. Its authors declare a financial stake in the company that makes the monitor.
That is a small, early signal rather than a finding about stress, and a study of 105 people cannot separate stress from sleep, activity and diet. What it does show is that researchers are beginning to look at glucose variability alongside sleep and activity, in the same way they already look at HRV.
Want the full evidence review?
Six biomarker systems, a reflective self-check, and what the research does and doesn't show about each.
Where the honest caution belongs
A device measuring HRV or glucose variability is giving you a data trend, not a verdict. Several of the same research teams validating these devices are equally clear that ultra-short HRV readings carry reliability limits compared to longer clinical measurements, and that accuracy varies between devices, wear position, and even how still you're sitting when the reading happens.
In plain terms: a rough night on your recovery score isn't a diagnosis, and a green ring on your app isn't a clean bill of health. These tools are best used the way a good weather forecast is used, as a trend worth paying attention to, not a fact to build your identity around.
So what should you do with the data?
If you're already wearing something that tracks HRV, sleep, or glucose, the most useful shift isn't buying a fancier device, it's changing what question you ask the data. Instead of "is this number good or bad today," try "what does the trend over the last two to three weeks look like, and does it move in the direction I'd expect when I'm resting versus when I'm not."
This is exactly the kind of practical, evidence-grounded question we'll keep exploring, including a closer look at vagus nerve function and the cholinergic anti-inflammatory reflex, and what HbA1c reveals about long-term stress load, both of which show up in the numbers you're already collecting. If you're curious how reliable that wrist or ring data is device by device, we've broken down the 2025-2026 validation studies in detail.
Sources
Findings referenced above draw on a 2022 MDPI Sensors pilot study on smartwatch HRV and stress detection, a Texas Heart Institute research review on wearable HRV monitoring, a 2025 Nature Scientific Data continuous HRV/sleep dataset study, a 2024 Scientific Reports study of the Ultrahuman M1 continuous glucose monitor in non- and pre-diabetic Indians (doi 10.1038/s41598-024-56933-2), and Balia et al. (Stress and Health, 2026;42(4):e70205), a systematic review of 111 studies on burnout biomarkers.
Start with a baseline
The Stress Biomarker Checklist
A 13-page evidence review covering six biomarker systems, a reflective self-check, and what the research does and doesn’t show about each. Free.
Start with the Self-Check on page 11. It takes about four minutes.
The Capio Initiative is an educational platform, not a medical practice. The biomarkers discussed here help explain stress physiology. None of them can diagnose burnout, and we never use them to diagnose anything. Speak with a qualified healthcare professional before changing anything about your recovery or your use of tracking devices.
